Table 3.

HIV prevalences in HIV indicator conditions in the primary analysis.

HIV indicator condition	ICD-10 codes	Sample size	HIV prevalence in % (95%-CI)
Pneumocystosis	B48.5, B59	615	40.33 (36.42–44.23)
Oral hairy leukoplakia	K13.3	158	36.71 (29.11–44.3)
Kaposi's sarcoma	C46	998	29.86 (27.05–32.77)
Syphilis	A50, A51, A52, A53	12,939	11.49 (10.95–12.05)
Gonococcal infection	A54	6305	6.92 (6.31–7.55)
Acute hepatitis C	B17.1	9128	3.13 (2.78–3.49)
Malignant neoplasm of anus and anal canal	C21	4791	2.94 (2.46–3.42)
Chronic viral hepatitis	B18	9620	2.93 (2.6–3.26)
Anogenital (venereal) warts	A63.0	6261	2.86 (2.46–3.27)
Chlamydial infection	A55, A56	6020	2.24 (1.88–2.62)
Acute hepatitis B	B16	9975	1.66 (1.41–1.91)
Papillomavirus as the cause of diseases	B97.7	3887	1.65 (1.26–2.06)
Tuberculosis	A15, A16, A17, A18, A19	17,107	1.57 (1.39–1.76)
Hodgkin's lymphoma	C81	7981	1.13 (0.9–1.37)
Acute hepatitis A	B15	9090	1.08 (0.87–1.29)
Pneumonia	J10.0, J11.0, J12, J13, J14, J15, J16, J17, J18	24,013	0.91 (0.79–1.03)
Non-Hodgkin's lymphoma	C82, C83, C84, C85, C86	23,271	0.53 (0.44–0.63)
Infectious mononucleosis	B27	6858	0.39 (0.26–0.55)
Herpes simplex infections	B00	5877	0.39 (0.24–0.56)
Abnormal weight loss	R63.4	4262	0.38 (0.21–0.56)
Candidiasis	B37	5146	0.35 (0.19–0.52)
Herpes zoster	B02	4635	0.35 (0.19–0.52)
Dysplasia/malignant neoplasm of cervix uteri	C53, N87	14,508	0.26 (0.18–0.35)
Trichomoniasis	A59	6512	0.26 (0.14–0.4)
Malignant neoplasm of bronchus and lung	C34	2467	0.24 (0.08–0.45)
Seborrheic dermatitis	L21	6229	0.22 (0.11–0.35)